For the Inventor, By the Inventor

Enter assignee name

Plans-les-Ouates, Switzerland

Anteis S.a.

USPTO Granted Patents = 19

CIPO Patents = 1

EPO Patents = 11

Trademarks = 12

Forward Citations = 212

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Samuel Gavard Molliard (8 out of 8 patents)

Frank Dreher (4 out of 7 patents)

Cyrille Vinchon (4 out of 4 patents)

4. Gilles Bos (2 out of 4 patents)

5. Christophe Chedal Anglay (2 out of 2 patents)

6. Karine Mondon (1 out of 1 patent)

7. Olivier Benoit (1 out of 3 patents)

8. Bénédicte Vincente Tauzin (1 out of 1 patent)

9. Laurence Hermitte (1 out of 1 patent)

10. Vincent Guist'Hau (0 patent)

11. Karin Mondon (0 patent)

12. Samuel Gavard (0 patent)

19 patents: Sort by Forward Citations

1. 11382853 - Hyaluronic acid dermal fillers crosslinked with citric acid, method for making same and uses thereof (2022-07-12),

2. 11331305 - Peptides for skin rejuvenation and methods of using the same (2022-05-17),

3. 10543195 - Peptides for skin rejuvenation and methods of using the same (2020-01-28),

4. 10493006 - Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use (2019-12-03),

5. 10463762 - Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use (2019-11-05),

6. 10434040 - Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use (2019-10-08),

7. 10272181 - Method for obtaining an injectable hydrogel based on hyaluronic acid containing lidocaine and an alkaline agent, sterilized with heat (2019-04-30),

8. 9782490 - Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel (2017-10-10),

9. 9713604 - Antioxidant compositions and methods of using the same (2017-07-25),

10. 9629856 - Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds (2017-04-25),

11. 9623150 - Injectable hydrogel for the long-term supplementation of glycerol in the skin (2017-04-18),

12. 9468779 - Viscoelastic gel for dermatological use (2016-10-18),

13. D702835 - Needle retaining device (2014-04-15),

14. 8685944 - Viscoelastic gel for dermatological use (2014-04-01),

15. 8574629 - Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume (2013-11-05),

ANTEIS S.A. is a leading biotechnology company specializing in the field of aesthetic medicine. With a focus on developing innovative products and solutions, ANTEIS aims to provide safe and effective treatments for patients worldwide. Their extensive portfolio includes dermal fillers, tissue regenerating products, and bioresorbable medical devices. Committed to quality and scientific excellence, ANTEIS collaborates with experts, physicians, and research institutions to continually advance their products and improve patient care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

19 Patents

#1 in Plans-les-Ouates

#660 in Switzerland

#31,677 in the World

Plans-les-Ouates, Switzerland

Anteis S.a.

Forward Citations = 212

9 inventors:

Samuel Gavard Molliard (8 out of 8 patents)

Frank Dreher (4 out of 7 patents)

Cyrille Vinchon (4 out of 4 patents)

4. Gilles Bos (2 out of 4 patents)

5. Christophe Chedal Anglay (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…